These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24923289)

  • 1. Predictors of metabolic risk in childhood obesity.
    Morandi A; Maffeis C
    Horm Res Paediatr; 2014; 82(1):3-11. PubMed ID: 24923289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circle.
    Alterio A; Alisi A; Liccardo D; Nobili V
    Horm Res Paediatr; 2014; 82(5):283-9. PubMed ID: 25324136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study.
    Kelishadi R; Cook SR; Motlagh ME; Gouya MM; Ardalan G; Motaghian M; Majdzadeh R; Ramezani MA
    J Am Diet Assoc; 2008 Jan; 108(1):82-90. PubMed ID: 18155992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.
    Boyraz M; Hatipoğlu N; Sarı E; Akçay A; Taşkın N; Ulucan K; Akçay T
    Obes Res Clin Pract; 2014; 8(4):e356-63. PubMed ID: 25091357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related consequences of childhood obesity.
    Kelsey MM; Zaepfel A; Bjornstad P; Nadeau KJ
    Gerontology; 2014; 60(3):222-8. PubMed ID: 24434909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.
    Vinciguerra F; Baratta R; Farina MG; Tita P; Padova G; Vigneri R; Frittitta L
    Acta Diabetol; 2013 Jun; 50(3):443-9. PubMed ID: 23447004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation and prevention of type II diabetes mellitus and cardiovascular diseases in obese children and adolescents: a public health intervention in a local health organisation in Rome (Italy)].
    Doro Altan AM; Manca Bitti ML; Buonomo E; Scarcella P; Mancinelli S; Arcano S; Palombi L
    Ig Sanita Pubbl; 2008; 64(3):345-60. PubMed ID: 18936798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic consequences of childhood obesity.
    Weiss R; Caprio S
    Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):405-19. PubMed ID: 16150383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child.
    l'Allemand-Jander D
    Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S32-6. PubMed ID: 21151144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative relationship between liver fat content and metabolic syndrome in obese children and adolescents.
    Zhang H; Yang H; Lai C; Xu X; Huang K; Fu J
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):43-9. PubMed ID: 25711346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome in young people.
    Poyrazoglu S; Bas F; Darendeliler F
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):56-63. PubMed ID: 24247648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory assessment of cardiometabolic risk in overweight and obese children.
    Sypniewska G
    Clin Biochem; 2015 Apr; 48(6):370-6. PubMed ID: 25583095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
    Nathan BM; Moran A
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in obese Thai children and adolescents.
    Iamopas O; Chongviriyaphan N; Suthutvoravut U
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S126-32. PubMed ID: 22043765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis.
    Reinehr T; Woelfle J; Wunsch R; Roth CL
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2143-50. PubMed ID: 22438225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation.
    Bizzarri C; Pinto RM; Ciccone S; Brescia LP; Locatelli F; Cappa M
    Pediatr Blood Cancer; 2015 Sep; 62(9):1650-5. PubMed ID: 26017459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic contribution to obesity.
    Ouni M; Schürmann A
    Mamm Genome; 2020 Jun; 31(5-6):134-145. PubMed ID: 32279091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Obesity in childhood].
    Shcherbakova MIu; Poriagina GI; Kovaleva EA
    Eksp Klin Gastroenterol; 2010; (7):74-83. PubMed ID: 21033087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.